Real-world experience of adjunct weekly semaglutide in Type 1 diabetes. Is it worth it?

被引：0
|
作者：
Cohen, Neale [1 ]
Yeung, Asher [1 ,2 ]
Jenkins, Alicia [1 ,2 ]
机构：
[1] Baker Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia
[2] Chinese Univ Hong Kong, Hong Kong, Peoples R China
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2025年 / 219卷
关键词：
METABOLIC SYNDROME;
D O I：
10.1016/j.diabres.2024.111979
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-World HbA1c Changes Among Type 2 Diabetes Mellitus Patients Initiating Treatment With a 1.0 mg Weekly Dose of Once-Weekly Semaglutide for Diabetes
    Gronroos, Noelle N.
    Swift, Caroline
    Frazer, Monica S.
    Sargent, Andrew
    Leszko, Michael
    Buysman, Erin
    Alvarez, Sara
    Dunn, Tyler J.
    Noone, Josh
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2024, 11 (02): : 118 - 124
  • [22] Real-World Impact of Once-Weekly Injectable Semaglutide on Glycemic Control and Weight Outcomes in Type 2 Diabetes (RELATE-OW Injectable Semaglutide)
    Amamoo, James
    Doshi, Riddhi P.
    Noone, Joshua
    Tan, Xi
    Xie, Lin
    Gamble, Cory L.
    Guevarra, Mico
    Chen, Justin
    King, Aaron A.
    DIABETES, 2023, 72
  • [23] Real-world HbA1c changes and prescription characteristics among type 2 diabetes mellitus patients initiating treatment with once weekly semaglutide for diabetes
    Frazer, Monica
    Swift, Caroline
    Sargent, Andrew
    Leszko, Michael
    Buysman, Erin
    Gronroos, Noelle N.
    Alvarez, Sara
    Dunn, Tyler J.
    Noone, Josh
    Gamble, Cory L.
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2024, 23 (01) : 783 - 788
  • [24] Once-weekly semaglutide use in patients with type 2 diabetes: Real-world data from the SURE Italy observational study
    Napoli, Raffaele
    Berra, Cesare
    Catarig, Andrei-Mircea
    Di Loreto, Chiara
    Donatiello, Emily
    Berentzen, Tina Landsvig
    Pitocco, Dario
    Giorgino, Francesco
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1658 - 1667
  • [25] Once-weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: Real-world data from a diabetes out-patient clinic
    Hansen, Katrine B.
    Svendstrup, Mathilde
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    Vestergaard, Henrik
    DIABETIC MEDICINE, 2021, 38 (10)
  • [26] Semaglutide Once-Weekly Persistence and Adherence Versus Other GLP-1 RAs in Patients with Type 2 Diabetes in a US Real-World Setting
    Chioma Uzoigwe
    Yuanjie Liang
    Sarah Whitmire
    Yurek Paprocki
    Diabetes Therapy, 2021, 12 : 1475 - 1489
  • [27] Semaglutide Once-Weekly Persistence and Adherence Versus Other GLP-1 RAs in Patients with Type 2 Diabetes in a US Real-World Setting
    Uzoigwe, Chioma
    Liang, Yuanjie
    Whitmire, Sarah
    Paprocki, Yurek
    DIABETES THERAPY, 2021, 12 (05) : 1475 - 1489
  • [28] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
    Holmes, Patrick
    Bell, Heather Elizabeth
    Bozkurt, Karan
    Catarig, Andrei-Mircea
    Clark, Alice
    Machell, Alena
    Sathyapalan, Thozhukat
    DIABETES THERAPY, 2021, 12 (11) : 2891 - 2905
  • [29] Real-world use of once-weekly semaglutide in diverse patient populations with type 2 diabetes: pooled analysis of four SURE studies
    Yale, J. -F.
    Catarig, A. -M.
    Catrina, S. -B.
    Erhan, U.
    Sathyapalan, T.
    Schultes, B.
    Tariq, M.
    Knudsen, S. T.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 230 - 230
  • [30] Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study)
    Mateos, Irene Caballero
    de Lucas, Maria Dolores Garcia
    Doulatram-Gamgaram, Viyey Kishore
    Moreno-Moreno, Paloma
    Jimenez-Millan, Ana Isabel
    Botana-Lopez, Manuel
    Merino-Torres, Juan Francisco
    Soto-Gonzalez, Alfonso
    Fernandez-Garcia, Jose Carlos
    Morales-Portillo, Cristobal
    NUTRIENTS, 2024, 16 (15)
12345